Noah Auerhahn Net Worth (Estimated)
Founder at Uncommon Therapeutics · YC W25
Quick answer
Noah Auerhahn's estimated net worth / paper wealth is $10.0M (range $7.0M–$15.0M) as of 2026.
Noah Auerhahn is Founder at Uncommon Therapeutics (YC W25). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Region: United States of America
- Industries: Healthcare, Therapeutics
- Team size: 2
- Website: https://uncommontherapeutics.com
Who is Noah Auerhahn?
Noah Auerhahn is a founder known for his work at Uncommon Therapeutics, participating in Y Combinator's Winter 2025 batch.
Highlights:
- Y Combinator W25
About Uncommon Therapeutics
Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.
Model inputs
- Stage: seed
- Valuation tier: fallback-seed
- Valuation note: no_discovery_sources [scale: $500k-class amount looked like a YC check, not a published seed]
- Research as-of: 2026-08-04
- Funding input: no public raise amount found; stage fallback valuation
FAQ: Noah Auerhahn net worth and Uncommon Therapeutics valuation
What is Noah Auerhahn's net worth?
Noah Auerhahn's estimated net worth / paper wealth is $10.0M (range $7.0M–$15.0M) as of 2026. Entrepreneurial Check publishes an independent model-based estimate from public company and role data.
Noah Auerhahn net worth
Noah Auerhahn's estimated net worth / paper wealth is $10.0M (range $7.0M–$15.0M) as of 2026. This Noah Auerhahn net worth figure is estimated paper wealth, not a verified statement of assets.
How much is Noah Auerhahn worth?
Noah Auerhahn's estimated net worth / paper wealth is $10.0M (range $7.0M–$15.0M) as of 2026. How much Noah Auerhahn is worth here means estimated paper wealth from public company and role data — not financial advice.
How rich is Noah Auerhahn?
Noah Auerhahn's estimated net worth / paper wealth is $10.0M (range $7.0M–$15.0M) as of 2026. “How rich is Noah Auerhahn” here means estimated paper wealth from public company and role data — not verified net worth or financial advice.
Noah Auerhahn fortune
Noah Auerhahn's estimated net worth / paper wealth is $10.0M (range $7.0M–$15.0M) as of 2026. This Noah Auerhahn fortune figure is estimated paper wealth only, not a verified statement of assets.
Noah Auerhahn equity value
Noah Auerhahn's estimated net worth / paper wealth is $10.0M (range $7.0M–$15.0M) as of 2026. Noah Auerhahn equity value on this page is modeled paper wealth from estimated ownership — not a disclosed cap table or verified net worth.
What is Uncommon Therapeutics valuation?
Uncommon Therapeutics's estimated valuation on Entrepreneurial Check is $20.0M. Independent model output, not a verified appraisal or official mark.
What is Uncommon Therapeutics post-money valuation?
Uncommon Therapeutics's estimated valuation on Entrepreneurial Check is $20.0M. That figure is a modeled post-money mark when a public raise is available — not a verified appraisal or official mark.
What is Uncommon Therapeutics funding?
Uncommon Therapeutics funding, when a public raise is available, is a model input on this Entrepreneurial Check profile. How much Uncommon Therapeutics raised is not a complete cap table — figures are estimates only.
How much did Uncommon Therapeutics raise?
How much Uncommon Therapeutics raised, when disclosed, informs the estimated Uncommon Therapeutics valuation and founder paper-wealth figures on this page. Independent estimate only — not a complete cap table or financial advice.
How much money did Uncommon Therapeutics raise?
How much money Uncommon Therapeutics raised, when a public figure is available, is a model input for the estimated Uncommon Therapeutics valuation on this profile. Estimates only — not a complete cap table.
What is Uncommon Therapeutics series funding?
Uncommon Therapeutics series funding, when a public raise is disclosed, informs the estimated Uncommon Therapeutics valuation here. Not a complete financing history.
What company is Noah Auerhahn building?
Noah Auerhahn is Founder at Uncommon Therapeutics, a Y Combinator-backed startup (batch W25).
What does Uncommon Therapeutics do?
Uncommon Therapeutics — A Disease Focused Biotech, Building Multiple Billion Dollar Drugs
What YC batch is Noah Auerhahn from?
Noah Auerhahn is associated with Y Combinator batch W25.
Where is Noah Auerhahn based?
Public directory data lists Noah Auerhahn's region as United States of America.
What industry is Noah Auerhahn in?
Noah Auerhahn is listed under Healthcare, Therapeutics.
How big is Uncommon Therapeutics?
Public data lists Uncommon Therapeutics's team size as 2.
What else is notable about Noah Auerhahn?
Y Combinator W25.
Is Entrepreneurial Check affiliated with Y Combinator?
No. Entrepreneurial Check is an independent informational site and is not affiliated with, endorsed by, or sponsored by Y Combinator or the profiled companies.